Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours
Technology appraisal guidance
Reference number: TA1034
Published:
The topic was considered by the Topic Selection Oversight Panel (TSOP) in January 2024. The panel concluded that a routing to the Technology Appraisal (TA) programme is appropriate for this topic.